This inventor holds 1 USPTO granted patent. Top assignee: Kainos Medicine Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yeontae Chung: Innovator in Alpha-Synuclein Modulation
Introduction
Yeontae Chung is a prominent inventor based in Seongnam, South Korea. He has made significant contributions to the field of medical research, particularly in the modulation of alpha-synuclein, a protein associated with neurodegenerative diseases.
Latest Patents
Yeontae Chung holds a patent titled "Modulators of Alpha-Synuclein." This patent represents his innovative approach to addressing the challenges posed by alpha-synuclein in medical science. He has 1 patent to his name, showcasing his commitment to advancing research in this critical area.
Career Highlights
Chung is currently employed at Kainos Medicine Inc., where he continues to develop groundbreaking solutions in the medical field. His work at Kainos Medicine Inc. reflects his dedication to improving health outcomes through innovative research.
Collaborations
Throughout his career, Yeontae Chung has collaborated with notable colleagues, including Boksuk Kim and Jae Moon Lee. These partnerships have enhanced his research efforts and contributed to the advancement of their shared goals in medical innovation.
Conclusion
Yeontae Chung is a dedicated inventor whose work in alpha-synuclein modulation is paving the way for future advancements in medical research. His contributions are vital to understanding and addressing neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile